Ted Nilsson, Pawel Rasinski, Örjan Smedby, Siri Af Burén, Ernesto Sparrelid, J Matthias Löhr, Thuy A Tran, August Blomgren, Antonios Tzortzakakis, Rimma Axelsson, Maria Holstensson
Fibroblast activation protein is a promising target for oncologic molecular imaging with radiolabeled fibroblast activation protein inhibitors (FAPI) in a large variety of cancers. However, there are yet no published recommendations on how to set up an optimal imaging protocol for FAPI PET/CT. It is important to optimize the acquisition duration and strive toward an acquisition that is sufficiently short while simultaneously providing sufficient image quality to ensure a reliable diagnosis. The aim of this study was to evaluate the feasibility of reducing the acquisition duration of [68 Ga]FAPI-46 imaging while maintaining satisfactory image quality, with certainty that the radiologist's ability to make a clinical diagnosis would not be affected...
April 16, 2024: Journal of Nuclear Medicine Technology